Article
Surprising leads for a cholera toxin receptor-binding antagonist: crystallographic studies of CTB mutants.
Structure (London, England : 1993) - 15 Jun 1995
Merritt E A, Sarfaty S, Chang T T, Palmer L M, Jobling M G, Holmes R K, Hol W G
Abstract excerpt
BACKGROUND: Because agents which inhibit the receptor binding of cholera toxin constitute possible lead compounds for the structure-based design of anti-cholera drugs, detailed investigation of the toxin's receptor-binding site is of key importance. The substitution Gly-->Asp at residue 33 of the cholera toxin B subunit (CTB) has been reported to abolish receptor-binding ability. The substitution Arg35-->Asp has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
